 | Up a level |
Journal Article
Borrega, Jorge Garcia, Boell, Boris, Kochanek, Matthias, Naendrup, Jan-Hendrik, Simon, Florian, Sieg, Noelle, Hallek, Michael, Borchmann, Peter, Holtick, Udo, Shimabukuro-Vornhagen, Alexander, Eichenauer, Dennis A. and Heger, Jan-Michel 
ORCID: 0000-0001-9463-8504
(2023).
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis.
Ann. Hematol., 102 (1).
S. 191 - 198.
NEW YORK:
SPRINGER.
ISSN 1432-0584
Borchmann, Peter, Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Mahlich, Jorg ORCID: 0000-0003-1110-2793, Papadimitrious, Michael S., Riou, Sybille and Werner, Barbara
(2023).
Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis.
Oncol. Ther., 11 (1).
S. 65 - 82.
NEW YORK:
SPRINGER.
ISSN 2366-1089
Heger, Jan-Michel ORCID: 0000-0001-9463-8504 and Borchmann, Sven
(2022).
Coming of age: the evolving role of circulating tumor DNA in malignant lymphoma.
Leuk. Lymphoma, 63 (4).
S. 768 - 771.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1029-2403
Graef, Claus Moritz, Goedel, Philipp, Falderbaum, Philipp, Balke-Want, Hyatt, Simon, Florian ORCID: 0000-0002-2700-3717, Sieg, Noelle, Naendrup, Jan-Hendrik, Neumann, Marie Anne-Catherine ORCID: 0000-0002-2396-6110, Gillessen, Sarah, Broeckelmann, Paul J., Eichenauer, Dennis A., Borchmann, Peter, von Tresckow, Bastian and Heger, Jan-Michel ORCID: 0000-0001-9463-8504
(2022).
Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma.
Eur. J. Haematol., 108 (5).
S. 403 - 413.
HOBOKEN:
WILEY.
ISSN 1600-0609
Gillessen, Sarah, Pluetschow, Annette, Vucinic, Vladan ORCID: 0000-0002-8398-285X, Ostermann, Helmut, Kobe, Carsten, Broeckelmann, Paul J., Boell, Boris, Eichenauer, Dennis A., Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian
(2022).
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
Eur. J. Haematol., 109 (6).
S. 728 - 736.
HOBOKEN:
WILEY.
ISSN 1600-0609
Kaddu-Mulindwa, Dominic ORCID: 0000-0001-8832-252X, Godel, Philipp, Kutsch, Nadine, Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Scheid, Christof, Borchmann, Peter, Holtick, Udo, Held, Gerhard, Thurner, Lorenz, Bewarder, Moritz, Rixecker, Torben and Bittenbring, Joerg-Thomas
(2022).
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.
Clin. Lymphoma Myeloma Leuk., 22 (7).
S. E498 - 9.
DALLAS:
CIG MEDIA GROUP, LP.
ISSN 2152-2669
Wolff, Jochen, Becker, Juergen, Naendrup, Jan-Hendrik, Borrega, Jorge Garcia, Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Hamacher, Laura, Boell, Boris, Eichenauer, Dennis A., Shimabukuro-Vornhagen, Alexander and Kochanek, Matthias
.
Team-specific impacts of the corona pandemic on intensive care medicine personnel of a maximum care hospital.
Med Klin Intensivmed Notfmed.
HEIDELBERG:
SPRINGER HEIDELBERG.
ISSN 2193-6226